On the bright side in North America, the Revlon brand has reclaimed its lead in the US mass lip segment, and both Revlon and Almay are off to strong starts in the fourth quarter, company leadership says. The firm continues to build the international and digital sides of its business in search of sustainable growth outside of Elizabeth Arden.
Revlon Group Inc. is making strong headway in key strategic areas under CEO Debra Perelman, but its heavy exposure in North America weighed on overall third-quarter results in fiscal 2019.
The New York-based firm posted net sales of $596.8m for the quarter, down 7.1% in constant currency, marking a continuation...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
